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C O R R E S P O N D E N C E
Variable flagella expression among clonal toxin
A–/Bþ Clostridium difficile strains with highly
homogeneous flagellin genes
Colonization with Clostridium difficile may lead to
antibiotic-associated diarrhea (AAD), antibiotic-
associated colitis (AAC) or even pseudomembra-
nous colitis (PMC) [1]. In our university hospital in
Warsaw (Poland), for instance, 40% of all patients
with AAD are colonized with cultivable amounts
of C. difficile. C. difficile’s major virulence factors
involved are enterotoxin A and cytotoxin B [2].
Boriello et al. described the first strain that pro-
duced toxin B, but not toxin A. Interestingly, this
strain still caused disease in an animal model [3].
Recently, toxin A-negative, toxin B-positive (A–Bþ)
C. difficile strains were isolated from patients
involved in a Canadian nosocomial outbreak of
AAD [4]. In Poland, we have isolated similar
strains from children and adults with AAD; the
frequency with which these particular strains
occur equals 11% of all clinical isolates [5].
C. difficile possesses a number of additional
virulence factors [6]. Tasteyre et al. recently char-
acterized the 39-kDa flagellin protein and
sequenced its gene [7–9]. Within this fliC gene,
sequence variation was identified by PCR RFLP,
which provided markers of genetic variability [7].
The aim of our current study was to investigate
clonal Polish (A–Bþ) C. difficile strains [5] for the
presence of fliC and flagella by PCR RFLP and
electron microscopy (EM).
Nine (A–Bþ) C. difficile strains from fecal sam-
ples of patients suspected of having AAD were
studied (strains 2428/95, 2887/97, 2785/97, 399/
98, 592/98, 1110/98, 2233/98, 2601/98 and P205/
99 from Pituch et al. [5]). The strains are not out-
break related. They originated from different
patients, nursed in different departments at vary-
ing points in time. C. difficile strains were cultured
under anaerobic conditions on Columbia agar
plates supplemented with 5% sheep blood or on
brain–heart infusion medium for 48 h (bioMerieux,
Marcy-l’Etoile, France). Toxin detection and
genetic identification of the strains was performed
as described previously [5]. For EM, C. difficile
strains were grown on solid or liquid medium
and suspended in phosphate-buffered saline
(106 bacteria/mL). Formvar-coated supporting
grids were placed face down on a drop of the
suspension for 5 min. Excess liquid was removed,
and grids were stained with a 2% phosphotungstic
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Figure 1 Presence of flagella and lack of polymorphism in flagellin genes for toxin A–/Bþ strains isolated from Polish
patients suffering from AAD. (A) Electronmicrographs for C. difficile 2887/97 and 399/98. Bacteria were negatively stained
with phosphotungstate and the magnification was set at 12 000 (upper panel) and 16 000 (lower panel). Both bacterial
isolates produced significant amounts of intact flagella. (B) PCR RFLP analysis of the flagellin gene. DNA from the nine
strains was amplified with fliC-specific primers. The resulting amplicon was incubated with the restriction enzymes noted
on the right. HindIII fails to cut all fragments, and all of the other enzymes produce the same RFLP pattern for all of the
strains. The lane marked M harbors molecular size markers differing by 100 bp at regular intervals. The intensely staining
600-bp fragment is highlighted by the arrows on the left.
acid solution (pH 7.2) for 5 min. The grids were air
dried and observed under a Jem100 S (Jeol) trans-
mission electron microscope (Philips, Eindhoven,
The Netherlands). Detection and characterization
of the flagellin gene was performed precisely as
described by Tasteyre et al. [7].
As observed by EM, only three of nine (A–Bþ) C.
difficile strains produced visible flagella, whereas
six were clearly non-flagellated. The number per
cell and individual length of the flagella varied.
PCR amplification using primers Nter and Cter
produced the expected 870-bp product for all
strains. No significant sequence variability could
be shown by PCR RFLP analysis, despite the fact
that the amplified fragment of the fliC gene was
digested with HindIII, DraI, HpaI, PvuII, RsaI and
HincII. The overall RFLP type was not encountered
in the collection of strains analyzed by Tasteyre
et al. [7].
Flagella may be important virulence determi-
nants for several microbial species [10]. Some non-
flagellated bacteria possess cryptic flagellin genes
[11], whereas the expression of surface flagella in
some pathogenic bacteria is regulated by environ-
mental stimuli [12]. Little was known about the
flagella of C. difficile until 1997, when Tasteyre et al.
purified the flagellin of various strains [9]. Being
interested in Polish (A–Bþ) C. difficile strains, which
are usually highly resistant to clindamycin, we
decided to test those strains for the presence of
flagellin genes and flagella. Our observations are
in agreement with those described by Tasteyre
et al. [7], showing that fliC was present in both
flagellated and non-flagellated (A–Bþ) C. difficile
strains. However, we here for the first time show
that this phenomenon also occurs among strains
that are members of the same well documented
clonal lineage.
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